Inogen, Inc (INGN) vs Neuronetics, Inc. (STIM)
- Inogen, Inc INGN 6.25 −0.79%
- Neuronetics, Inc. STIM 1.89 −3.08%
Inogen, Inc and Neuronetics, Inc. are both Medical Devices companies. Inogen, Inc is the larger, with a market value of $167.1M against $148.6M — 1.1× the size. Neuronetics, Inc. grew revenue faster over the last twelve months: 39.6% against 3.15%. Inogen, Inc has the higher net margin (−6.94% vs −19.6%) and the lower return on invested capital (−28.4% vs −24.6%). Across the 18 metrics below, Inogen, Inc leads on 12 and Neuronetics, Inc. on 6.
Valuation
Profitability
| Metric | INGN | STIM | Medical Devices median |
|---|---|---|---|
| Gross margin | 44.51% | 49.12% | 56.01% |
| Operating margin | (8.71%) | (14.74%) | (15.03%) |
| Net margin | (6.94%) | (19.62%) | (20.40%) |
| Free cash flow margin | (2.22%) | (7.24%) | (7.24%) |
| Return on equity | (13.14%) | (114.52%) | (15.32%) |
| Return on assets | (8.23%) | (22.87%) | (19.72%) |
| Return on invested capital | (28.35%) | (24.64%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack